<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100962781</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22270</journal-id>
<journal-id journal-id-type="nlm-ta">Nat Rev Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat. Rev. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Nature reviews. Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1471-003X</issn>
<issn pub-type="epub">1471-0048</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28446786</article-id>
<article-id pub-id-type="pmc">5823005</article-id>
<article-id pub-id-type="doi">10.1038/nrn.2017.39</article-id>
<article-id pub-id-type="manuscript">NIHMS942706</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>How and why do T cells and their derived cytokines affect the injured and healthy brain?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Filiano</surname>
<given-names>Anthony J.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gadani</surname>
<given-names>Sachin P.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kipnis</surname>
<given-names>Jonathan</given-names>
</name>
</contrib>
<aff id="A1">Center for Brain Immunology and Glia, Department of Neuroscience, School of Medicine, University of Virginia, Charlottesville, Virginia 22908, USA</aff>
</contrib-group>
<author-notes>
<corresp id="FN1">Correspondence to: A.J.F. and J.K. <email>ajf5v@virginia.edu</email>; <email>kipnis@virginia.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>
<bold>Competing interests statement</bold>
</p>
<p>The authors declare no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>22</day>
<month>2</month>
<year>2018</year>
</pub-date>
<volume>18</volume>
<issue>6</issue>
<fpage>375</fpage>
<lpage>384</lpage>
<!--elocation-id from pubmed: 10.1038/nrn.2017.39-->
<abstract>
<p id="P1">The evolution of adaptive immunity provides enhanced defence against specific pathogens, as well as homeostatic immune surveillance of all tissues. Despite being ‘immune privileged’, the CNS uses the assistance of the immune system in physiological and pathological states. In this Opinion article, we discuss the influence of adaptive immunity on recovery after CNS injury and on cognitive and social brain function. We further extend a hypothesis that the pro-social effects of interferon-regulated genes were initially exploited by pathogens to increase host–host transmission, and that these genes were later recycled by the host to form part of an immune defence programme. In this way, the evolution of adaptive immunity may reflect a host–pathogen ‘arms race’.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>